R$1.00 ($0.19)

-0.01 (-0.99%)

Weekly Expected Move ±16.3%

R$1 R$1 R$1 R$1 R$1

SAO · Healthcare · Medical - Care Facilities · Tech Score Strong Sell · Power 30 · R$1.1B mcap · 723M float · 2.41% daily turnover

Revenue

$6.2B +13.5% ▲

5Y CAGR: +29.8%

Gross Profit

$2.1B +6.8% ▲

5Y CAGR: +34.9%

Operating Income

-$120M -115.8% ▼

Net Income

-$646M -389.0% ▼

EPS (Diluted)

$-1.05 -350.0% ▼

EBITDA

$271M -75.8% ▼

5Y CAGR: +7.8%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$2.0B	$2.7B	$4.1B	$5.5B	$6.2B
YoY Growth	+20.5%	+32.8%	+51.3%	+34.3%	+13.5%
Cost of Revenue	$1.4B	$1.8B	$2.6B	$3.6B	$4.2B
Gross Profit	$636M	$869M	$1.5B	$1.9B	$2.1B
Gross Margin	31.2%	32.2%	35.5%	35.1%	33.1%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$604M	$688M	$981M	$1.2B	$1.4B
Operating Expenses	$616M	$692M	$982M	$1.2B	$2.2B
Operating Income	$32M	$177M	$471M	$758M	-$120M
Operating Margin	1.6%	6.6%	11.5%	13.8%	-1.9%
Interest Expense	$95M	$154M	$433M	$560M	$602M
Income Before Tax	-$53M	$62M	$122M	$303M	-$657M
Tax Expense	$68M	$85M	$8M	-$10M	$61M
Net Income	-$158M	-$47M	$46M	$224M	-$646M
Net Margin	-7.7%	-1.7%	1.1%	4.1%	-10.4%
EPS (Diluted)	$-0.39	$-0.10	$0.09	$0.42	$-1.05
EBITDA	$148M	$344M	$693M	$1.1B	$271M
Shares Outstanding	402M	475M	532M	536M	616M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.6B	$1.6B	$1.5B	$1.5B	$1.4B	$1.4B	$1.2B	$1.0B
Cost of Revenue	$1.1B	$1.1B	$1.1B	$1.0B	$960M	$888M	$813M	$818M
Gross Profit	$548M	$503M	$412M	$440M	$453M	$481M	$348M	$229M
Gross Margin	33.5%	32.1%	27.6%	30.0%	32.1%	35.1%	30.0%	21.9%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$356M	$413M	$359M	$352M	$284M	$367M	$313M	$315M
Operating Expenses	$363M	$1.2B	$381M	$390M	$2.1B	$1.4B	$461M	$315M
Operating Income	$185M	-$703M	$31M	$50M	-$1.7B	-$885M	-$114M	-$86M
Operating Margin	11.3%	-44.9%	2.1%	3.4%	-117.7%	-64.7%	-9.8%	-8.2%
Interest Expense	$156M	$48M	$163M	$182M	$172M	$143M	$142M	$151M
Income Before Tax	$49M	-$717M	-$92M	-$130M	-$1.9B	-$1.1B	-$436M	-$483M
Tax Expense	$46M	$43M	$40M	$13M	$27M	$429M	$3M	-$7M
Net Income	-$16M	-$643M	-$146M	-$141M	-$1.9B	-$1.5B	-$364M	-$469M
Net Margin	-1.0%	-41.1%	-9.8%	-9.6%	-133.2%	-106.2%	-31.4%	-44.8%
EPS (Diluted)	$-0.03	$-1.02	$-0.25	$-0.22	$-2.79	$-2.16	$-0.41	$-0.72
EBITDA	$278M	-$455M	$140M	$104M	-$1.6B	-$864M	-$41M	-$17M
Shares Outstanding	584M	633M	597M	648M	674M	674M	881M	652M

ONCO3.SA SAO